The chick as a model for the study of the cellular mechanisms and potential therapies for Alzheimer's disease
- PMID: 20721285
- PMCID: PMC2915614
- DOI: 10.4061/2010/180734
The chick as a model for the study of the cellular mechanisms and potential therapies for Alzheimer's disease
Abstract
While animal experiments have contributed much to our understanding of the mechanisms of Alzheimer's disease (AD), their value in predicting the effectiveness of treatment strategies in clinical trials has remained controversial. The disparity between the results obtained in animal models and clinical trials may in part be explained by limitations of the models and species-specific differences. We propose that one trial passive avoidance in the day-old chick is a useful system to study AD because of the close sequence homologies of chick and human amyloid precursor protein (APP). In the chick, APP is essential for memory consolidation, and disrupting its synthesis or structure results in amnesia. RER, a tripeptide sequence corresponding to part of the growth domain of APP, can restore memory loss and act as a cognitive enhancer. We suggest that RER and its homologues may form the basis for potential pharmacological protection against memory loss in AD.
Figures




Similar articles
-
The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by A beta and acts as a cognitive enhancer.Eur J Neurosci. 2004 Apr;19(7):1933-8. doi: 10.1111/j.1460-9568.2004.03276.x. Eur J Neurosci. 2004. PMID: 15078567
-
Amyloid precursor protein: from synaptic plasticity to Alzheimer's disease.Ann N Y Acad Sci. 2005 Jun;1048:149-65. doi: 10.1196/annals.1342.014. Ann N Y Acad Sci. 2005. PMID: 16154929
-
The memory enhancing effect of the APP-derived tripeptide Ac-rER is mediated through CRMP2.J Neurochem. 2011 Aug;118(4):616-25. doi: 10.1111/j.1471-4159.2011.07193.x. Epub 2011 Feb 24. J Neurochem. 2011. PMID: 21255016
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.Neurobiol Dis. 2019 Dec;132:104541. doi: 10.1016/j.nbd.2019.104541. Epub 2019 Jul 23. Neurobiol Dis. 2019. PMID: 31349033 Free PMC article. Review.
Cited by
-
Origins of Knowledge: Insights from Precocial Species.Front Behav Neurosci. 2015 Dec 9;9:338. doi: 10.3389/fnbeh.2015.00338. eCollection 2015. Front Behav Neurosci. 2015. PMID: 26696856 Free PMC article. Review.
-
An Essential Role for Alzheimer's-Linked Amyloid Beta Oligomers in Neurodevelopment: Transient Expression of Multiple Proteoforms during Retina Histogenesis.Int J Mol Sci. 2022 Feb 17;23(4):2208. doi: 10.3390/ijms23042208. Int J Mol Sci. 2022. PMID: 35216328 Free PMC article.
References
-
- Porsolt RD. Animal models of depression: utility for transgenic research. Reviews in the Neurosciences. 2000;11(1):53–58. - PubMed
-
- Kalueff AV, Wheaton M, Murphy DL. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behavioural Brain Research. 2007;179(1):1–18. - PubMed
-
- Fujii T, Kunugi H. p75NTR as a therapeutic target for neuropsychiatric diseases. Current Molecular Pharmacology. 2009;2(1):70–76. - PubMed
-
- Moisan MP, Ramos A. Rat genomics applied to psychiatric research. Methods in Molecular Biology. 2010;597:357–388. - PubMed
-
- Hart PC, Bergner CL, Smolinsky AN, et al. Experimental models of anxiety for drug discovery and brain research. Methods in Molecular Biology. 2010;602:299–321. - PubMed
LinkOut - more resources
Full Text Sources